Alvotech Holdings S.A Logo

Alvotech Holdings S.A

ALVO | LuxSE

Overview

Corporate Details

ISIN(s):
LU2458332611
LEI:
222100DCZBOWV5DZ8372
Country:
Luxembourg
Address:
9, RUE DE BITBOURG, L-1273 LUXEMBOURG
Sector:
Health Care
Industry:
Biotechnology

Description

We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do. We have a deep appreciation for the positive impact biologic medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines are revolutionizing the way we treat diseases and improve patient lives. It is our aim to broaden the availability of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars. Our commitment to the promise of biosimilars is foundational to our approach, our culture and the strong sense of purpose that inspires us to work smarter and faster towards this mission. We are driven by passion - if there is a proven biologic medicine, we believe it should be accessible to all patients in need.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-26 10:01
Directors' Dealings
Notification Managers Transaction - Alvotech - Alvogen Lux Holdings S.à r.l.
English 84.5 KB
2025-05-20 09:24
Directors' Dealings
Managers' Transaction Notification R. Davies (20250516)
English 84.1 KB
2025-05-13 17:44
Regulatory News Service
pdf1278040195305217091
English 84.5 KB
2025-05-12 10:18
Regulatory News Service
Managers' Transaction Notification (20250512)
English 55.7 KB
2025-04-30 20:07
Regulatory News Service
222100DCZBOWV5DZ8372-2024-12-31-en (2)
English 1.3 MB
2025-04-30 20:07
Regulatory News Service
4be7257a-c4d2-4fa3-bc77-2b60162f8a38
English 10.0 MB
2025-01-15 22:00
Directors' Dealings
ATP Holdings ehf. - Managers' Transaction Notification (PCA)
English 49.4 KB
2024-12-30 23:41
Directors' Dealings
pdf5009312744798760428 (1)
English 49.5 KB
2024-10-30 12:30
Earnings Release
Alvotech to Report Financial Result..
Icelandic 3.9 KB
2024-10-30 12:30
Earnings Release
Alvotech to Report Financial Result..
English 5.8 KB
2024-10-10 10:01
Regulatory News Service
European Medicines Agency Confirms Acceptance of Marketing Application for AVT0…
Icelandic 8.7 KB
2024-10-10 10:01
Regulatory News Service
European Medicines Agency Confirms Acceptance of Marketing Application for AVT0…
English 14.4 KB
2024-10-01 20:03
Interim Report
Unaudited Consolidated Financial Statements Q2 2024
English 345.5 KB
2024-08-29 23:22
Regulatory News Service
Registration Statement Declared Effective
Icelandic 1.3 KB
2024-08-29 23:22
Prospectus
Registration Statement Declared Effective
English 1.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cinclus Pharma Holding AB Logo Cinclus Pharma Holding AB Sweden CINPHA
Circio Holding ASA Logo Circio Holding ASA Norway CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo CIZZLE BIOTECHNOLOGY HOLDINGS PLC United Kingdom CIZ
CLAL Biotechnology Industries Ltd. Logo CLAL Biotechnology Industries Ltd. Israel CBI
Combigene AB Logo Combigene AB Sweden COMBI
Compugen Ltd. Logo Compugen Ltd. Israel CGEN
Corline Biomedical AB Logo Corline Biomedical AB Sweden CLBIO
Curasight A/S Logo Curasight A/S Denmark CURAS
Curevac Logo Curevac Germany CVAC
Cyclezyme AB Logo Cyclezyme AB Sweden CYCLE